KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Depreciation & Amortization (CF) (2018 - 2025)

LifeMD's Depreciation & Amortization (CF) history spans 10 years, with the latest figure at $256431.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 77.7% year-over-year to $256431.0; the TTM value through Dec 2025 reached $4.0 million, up 67.56%, while the annual FY2025 figure was $866000.0, 86.03% down from the prior year.
  • Depreciation & Amortization (CF) reached $256431.0 in Q4 2025 per LFMD's latest filing, down from $262747.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.8 million in Q2 2025 to a low of $10695.0 in Q4 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $399667.3, with a median of $57666.0 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): rose 13.92% in 2023, then skyrocketed 2628.17% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $10695.0 in 2021, then surged by 319.61% to $44877.0 in 2022, then increased by 28.5% to $57666.0 in 2023, then skyrocketed by 150.24% to $144302.0 in 2024, then soared by 77.7% to $256431.0 in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Depreciation & Amortization (CF) are $256431.0 (Q4 2025), $262747.0 (Q3 2025), and $1.8 million (Q2 2025).